Innovation

Rapid Inexpensive Fluoroimmunoassay Diagnostic Chip Fabricated from Polyolefin Coated with a Thin Film

University of California System: University of California, Irvine
posted on 01/30/2012

Immunoassays have a tremendous range of uses in the diagnosis of diseases, pharmaceutical drug development studies, and therapeutic drug monitoring.They are highly popular due to their high specificity and sensitivity for a variety of analytes in biological samples.However, immunoassays can be labor intensive, time consuming, and require expensive reagents.An immunoassay method that is rapid, inexpensive, and highly effective would be practical and may have widespread use. Researchers at the University of California, Irvine have developed a fluoroimmunoassay chip that can be used for improving the detection of low concentration (approx. 1 nM) biological agents.The method is rapid, inexpensive, and provides a fluorescence enhancement that is approximately 30-fold greater than glass.In addition, this method does not use the principle of metal enhanced fluorescence to enhance the signal, so the fluorophore is not distance dependent in order to achieve enhancements.

Suggested Uses

The invention may be integrated into a microfluidic device and be used as an immunoassay to detect for infectious diseases.


Innovation Details
 

File Number: 22233 

Disease: Infectious Diseases


IP Protection

Copyright: ©2012, The Regents of the University of California

License Online

This innovation currently is not available for online licensing. Please contact the case manager at University of California System: University of California, Irvine for more information.

Request more info via email request more info
People

No people are currently associated with this innovation.


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Profile
Related Tags

Find more innovations


February 11, 2009

8,815 members 16,688 innovations 159 organizations

Browse

William Garner, M.D., MPH - CEO of Urigen, N.A., Inc.

"The iBridge Network provides an important additional pathway for entrepreneurs to access university innovations that may otherwise have been lost. The transparency of this pathway between entrepreneurs..."  read more...